NANeil M. Ampel

Neil M. Ampel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Neil M. Ampel has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Demosthenes Pappagianis

    Department of Immunobiology,1 Department of Medicine,2 Valley Fever Center for Excellence, University of Arizona, Tucson, Arizona,3 Department of Microbiology and Immunology, the University of California at Davis, Davis, California,4 the Southern Arizona Veterans Affairs Health Care System (SAVAHCS), Tucson, Arizona5

    3 shared publications
  • Lijin Li

    Medicine and Primary Care Service,1 Research Service, Southern Arizona Veterans Affairs Health Care System,2 Department of Medicine,3 Department of Microbiology and Immunology, University of Arizona, Tucson, Arizona,4 Department of Microbiology and Immunology, University of California at Davis, Davis, California5

    2 shared publications
  • Suzanne M. Johnson

    Department of Immunobiology,1 Department of Medicine,2 Valley Fever Center for Excellence, University of Arizona, Tucson, Arizona,3 Department of Microbiology and Immunology, the University of California at Davis, Davis, California,4 the Southern Arizona Veterans Affairs Health Care System (SAVAHCS), Tucson, Arizona5

    2 shared publications
  • Amanda B. Herman

    Medicine and Primary Care Service,1 Research Service, Southern Arizona Veterans Affairs Health Care System,2 Department of Medicine,3 Department of Microbiology and Immunology, University of Arizona, Tucson, Arizona,4 Department of Microbiology and Immunology, University of California at Davis, Davis, California5

    1 shared publication
  • D. Pappagianis

    1 shared publication
  • Daniel K. Nelson

    Medicine and Primary Care Service,1 Research Service, Southern Arizona Veterans Affairs Health Care System,2 Department of Medicine,3 Department of Microbiology and Immunology, University of Arizona, Tucson, Arizona,4 Department of Microbiology and Immunology, University of California at Davis, Davis, California5

    1 shared publication

Latest Publications

  • Polyfunctional T Lymphocytes Are in the Peripheral Blood of Donors Naturally Immune to Coccidioidomycosis and Are Not Induced by Dendritic Cells

    by Lance Nesbit, Suzanne M. Johnson, Demosthenes Pappagianis, Neil M. Ampel

    Coccidioidomycosis is a fungal infection endemic in the southwestern United States that is increasing in incidence. While cellular immunity correlates with protection from clinical illness, the precise elements of that response are undefined. Using the coccidioidal antigen preparation T27K and multiparametric flow cytometry, the in vitro frequency of polyfunctional T lymphocytes in the peripheral blood of naturally immune healthy donors and those who were nonimmune was determined. Polyfunctional CD4 lymphocytes, defined as producing intracellular interleukin 2 (IL-2), gamma interferon (IFN-γ), and tumor necrosis factor alpha simultaneously, had a frequency of 137 per 400,000 events among peripheral blood mononuclear cells (PBMC) of immune donors compared to 11 per 400,000 PBMC from nonimmune donors (P= 0.03). When monocyte-derived mature dendritic cells pulsed with T27K (mDCT27K) were used for antigen presentation, the frequency of polyfunctional CD4 T lymphocytes did not significantly increase for either group, although mDCT27Kdid significantly increase the concentrations of IL-2 and IFN-γ released by PBMC from nonimmune donors (P= 0.02). After in vitro stimulation with T27K, polyfunctional CD4 and CD8 lymphocytes of PBMC from immune donors had a mixture of low- and high-expression CCR7 cells, suggesting both effector and central memory, compared with predominantly high-expression CCR7 cells when PBMC were incubated with the mitogen phytohemagglutinin (P= 0.03). These data demonstrate the presence of polyfunctional T lymphocytes in the peripheral blood of individuals with coccidioidal immunity and suggest a model for the in vitro testing of vaccine candidates for coccidioidomycosis.


  • Preliminary Evaluation of Whole-Blood Gamma Interferon Release for Clinical Assessment of Cellular Immunity in Patients with Active Coccidioidomycosis

    by Neil M. Ampel, Daniel K. Nelson, Suzette Chavez, Kathryn A. Naus, Amanda B. Herman, Lijin Li, Keira A. Simmons, Demosthenes Pappagianis

    Assessment of the cellular immune response in coccidioidomycosis has epidemiologic and prognostic importance. Measurement of delayed-type hypersensitivity to skin testing has been used in the past to determine cellular immunity in coccidioidomycosis. However, no skin tests are currently available in the United States. Assay of gamma interferon (IFN-γ) release in whole blood in response to incubation with antigen has been used to assess cellular immunity in tuberculosis. We used a similar assay using the coccidioidal antigen preparation T27K to measure the in vitro cellular immune responses among a cohort of 69 subjects with active coccidioidomycosis. IFN-γ release was bimodal, with concentrations above and below 5 IU/ml. Using multivariate logistic regression, underlying disease and disseminated or chronic pulmonary coccidioidomycosis was significantly associated with the release of IFN-γ at a concentration of P = 0.02 or 0.05, respectively). In addition, the release IFN-γ concentration was P = 0.02). The release IFN-γ concentration correlated with expression of CD69 on T lymphocytes in an in vitro assay using T27K as the antigen (Spearman's rho = 0.59; P < 0.01). These results suggest that the IFN-γ release assay with T27K as the antigen may be a useful clinical test for assessing cellular immunity in patients with active coccidioidomycosis.


  • Combating opportunistic infections: coccidioidomycosis

    by Neil M Ampel

    Coccidioidomycosis is a growing problem in the southwestern US. Although most cases of symptomatic coccidioidomycosis occur in healthy individuals, individuals with depressed cellular immunity are at particular risk. These include individuals with HIV infection, those who have undergone allogeneic transplantation and others on immunosuppressive medications. Most instances of primary pulmonary coccidioidomycosis do not require antifungal therapy. However, almost all cases of disseminated coccidioidomycosis will require such therapy. The triazole antifungals, fluconazole and itraconazole, are effective therapies for coccidioidomycosis. Amphotericin B is now reserved for severe or recalcitrant cases. Coccidioidal meningitis requires lifelong therapy with triazole antifungals. Intrathecal amphotericin B is required for those cases that fail. Prevention of coccidioidomycosis by environmental control is difficult. In the future, immunisation or immune modulation may offer protection.

  • In Vitro Whole-Blood Analysis of Cellular Immunity in Patients with Active Coccidioidomycosis by Using the Antigen Preparation T27K

    by Neil M. Ampel, Larissa A. Kramer, Lijin Li, Deborah S. Carroll, Kathleen M. Kerekes, Suzanne M. Johnson, Demosthenes Pappagianis

    Measurement of cellular immunity in human coccidioidomycosis has important diagnostic and prognostic implications. The coccidioidin skin test has been the standard for the measurement of this, but it is not available in the United States. We examined the utility of measuring surface expression of CD69 on T lymphocytes in whole blood incubated with the coccidioidal antigen preparation T27K as an alternative to the skin test. Seventy donors with active coccidioidomycosis were studied. The mean fluorescent intensity (MFI) of CD69 expression on CD3 lymphocytes in response to T27K was 28.61 ± 1.77, significantly greater than the control response of 11.45 ± 0.78 ( P < 0.001). The MFI CD69 response to T27K above that for the control (MFI CD69 above control) was 6.35 ± 2.18 for seven subjects with disseminated coccidioidomycosis who were studied within 5 months of diagnosis. This was significantly below the value of 20.17 ± 3.17 for 18 subjects with pulmonary coccidioidomycosis studied within 5 months of diagnosis and the value of 19.58 ± 2.91 for 27 subjects with disseminated coccidioidomycosis studied after 5 months of diagnosis (for both, P < 0.05). There was an inverse correlation between coccidioidal clinical score and MFI CD69 above control for all 34 subjects with disseminated coccidioidomycosis ( r = 0.362; P = 0.036) but not for the 36 subjects with pulmonary disease ( r < 0.001; P = 0.993). Among 30 subjects for whom data were available, there was a highly significant association between the MFI CD69 above control and the supernatant concentrations of gamma interferon, interleukin-2 (IL-2), and tumor necrosis factor alpha (for all, P < 0.001), but not for IL-4, IL-5, or IL-10. These data indicate that in vitro assessment of CD69 expression on T lymphocytes by using T27K may be a useful measure of cellular immune response among subjects with active coccidioidomycosis.


  • Open Access

    Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood

    by N. M. Ampel, L. A. Kramer, K. M. Kerekes, S. M. Johnson, D. Pappagianis

    Whole blood flow cytometry was performed among donors with various clinical forms of coccidioidomycosis using T27K, a coccidioidal antigen preparation protective in mice but not previously studied in humans. The median percent of CD3+ lymphocytes (CD3+) producing intracellular interferon-gamma (IFN-γ) among healthy immune donors was 0·43%, significantly above that for non-immune donors (0·01%) and greater than that for subjects with other forms of coccidioidomycosis, including chronic pulmonary (0·11%), disseminated (0·09%) and concomitant human immunodeficiency virus (HIV) infection (0·07%) (P ≤0·002 for all). No increase in intracellular interleukin (IL)-10 production or apoptosis was noted in samples incubated with T27K. Among 14 HIV-infected patients with concomitant coccidioidomycosis, seven of eight patients whose peripheral blood CD4 concentration was >200 cells µl-1 had >0·06% of CD3+ produce intracellular IFN-γ, compared to none of six whose peripheral blood CD4+ lymphocyte concentration was ≤200 cells µl-1 (P = 0·005). These data indicate that there is a specific human cellular immune response to T27K as a coccidioidal antigen and that this response can be categorized based on the clinical status of the coccidioidally infected patient.


  • In vitro modulation of proliferation and cytokine production by human peripheral blood mononuclear cells from subjects with various forms of coccidioidomycosis

    by N M Ampel, L Christian

    Using peripheral blood mononuclear cells (PBMC) from individuals with or without coccidioidal delayed-type hypersensitivity (DTH), we examined and attempted to modulate the in vitro responses of PBMC from various donors to the coccidioidal antigen toluene spherule lysate (TSL). Among healthy DTH-positive donors, 100 ng of human recombinant interleukin-10 (IL-10) per ml suppressed both PBMC proliferation (P = 0.01) and gamma interferon (IFN-gamma) and IL-12 production (for both, P < 0.05). In vitro proliferation and production of IFN-gamma and IL-12 by PBMC were significantly higher in DTH-positive donors with active coccidioidomycosis than in healthy, nonimmune controls (P < 0.05) but not in active DTH-negative donors with or without human immunodeficiency virus infection (for both, P > 0.05). Human recombinant IL-12 increased IFN-gamma production by PBMC from active, DTH-positive donors (P = 0.01) but not by PBMC from DTH-negative groups. For healthy DTH-positive donors, the median antigen-reactive cell frequency per 10(5) PBMC was 3.7, compared to 1.7 in DTH-negative donors with active coccidioidomycosis (P = 0.03). These data indicate that the in vitro TSL response is highly dependent on coccidioidal DTH. Not only do PBMC from individuals with DTH appear to respond to TSL, but their response can be modulated in vitro with either IL-10 or IL-12. On the other hand, PBMC from DTH-negative individuals do not respond in vitro to TSL and their response is not modulable, suggesting a lack of antigen response.